9 months ago
ATHA
AnalystsGraig SuvannavejhGraig Suvannavejh's Stock Forecasts
AnalystsGraig Suvannavejh
Analyst Ranking
Bottom 14%
#4254 out of 4904 analysts
Average Return
-0.52%
Win Rate
48%59 out of 123
Risk vs Reward
Poor
Good
Graig Suvannavejh's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Insmed IncINSM | +266.11% | $20.36 | $74.54 | 2023-07-26 - 2024-07-26 | Strong Buy |
Insmed IncINSM | +197.15% | $23.88 | $70.96 | 2023-10-27 - 2024-10-25 | Strong Buy |
Insmed IncINSM | +168.79% | $26.43 | $71.04 | 2023-09-06 - 2024-09-06 | Strong Buy |
Insmed IncINSM | +162.29% | $25.83 | $67.75 | 2024-05-13 - 2025-05-12 | Strong Buy |
Halozyme Therapeutics IncHALO | +136.15% | $18.45 | $43.57 | 2020-01-08 - 2021-01-08 | Strong Buy |
Graig Suvannavejh Analyst Color
Get additional color on Graig Suvannavejh's coverage of popular stocks
a year ago
IMCR
a year ago
ITCI
a year ago
IMCR
a year ago
EYPT
a year ago
AXSM
a year ago
ADVM
2 years ago
BTAI
2 years ago
ITCI
2 years ago
AXSM
3 years ago
AXSM
3 years ago
HRMY
Graig Suvannavejh's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Insmed IncINSM | 7 | Buy | $110.00 | +13.54% | Maintains | 2 days ago |
Corvus Pharmaceuticals IncCRVS | 2 | Buy | $11.00 | +159.43% | Maintains | 25 days ago |
Eyepoint Pharmaceuticals IncEYPT | 5 | Buy | $26.00 | +193.45% | Maintains | a month ago |
Harmony Biosciences Holdings IncHRMY | 18 | Buy | $48.00 | +44.01% | Maintains | a month ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $20.00 | +3.84% | Maintains | a month ago |
Amylyx Pharmaceuticals IncAMLX | 7 | Buy | $8.00 | +44.93% | Maintains | a month ago |
Immunocore Holdings PLCIMCR | 8 | Hold | $33.00 | -7.38% | Maintains | 2 months ago |
Axsome Therapeutics IncAXSM | 21 | Buy | $216.00 | +103.29% | Maintains | 3 months ago |
Intra Cellular Therapies IncITCI | 11 | Hold | $132.00 | +0.10% | Downgrades | 4 months ago |
Adaptimmune Therapeutics PLCADAP | 2 | Buy | $1.50 | +509.76% | Maintains | 7 months ago |
Autolus Therapeutics PLCAUTL | 1 | Strong Buy | $7.60 | +253.49% | Upgrades | 7 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $74.00 | +706.98% | Reiterates | 9 months ago |
Athira Pharma IncATHA | 3 | Hold | $0.50 | +61.81% | Downgrades | 9 months ago |
Halozyme Therapeutics IncHALO | 4 | Hold | $49.00 | -10.16% | Maintains | a year ago |
Ideaya Biosciences IncIDYA | 1 | Buy | $50.00 | +124.42% | Initiates Coverage On | a year ago |
Neumora Therapeutics IncNMRA | 1 | Buy | $20.00 | +2,127.17% | Initiates Coverage On | a year ago |
Immatics NvIMTX | 3 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Adverum Biotechnologies IncADVM | 4 | Strong Buy | $22.00 | N/A | Maintains | a year ago |
Immuneering CorpIMRX | 1 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Cerevel Therapeutics Holdings IncCERE | 9 | Hold | $45.00 | N/A | Maintains | a year ago |
Terns Pharmaceuticals IncTERN | 5 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Alector IncALEC | 4 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Bioxcel Therapeutics IncBTAI | 8 | Hold | $64.00 | N/A | Reiterates | 2 years ago |
Karuna Therapeutics IncKRTX | 3 | Strong Buy | $258.00 | N/A | Maintains | 2 years ago |
Rain Oncology IncRAIN2 | 5 | Hold | $1.00 | N/A | Downgrades | 2 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $35.00 | N/A | Maintains | 3 years ago |
Kodiak Sciences IncKOD | 4 | Hold | $8.00 | N/A | Maintains | 3 years ago |
Tg Therapeutics IncTGTX | 2 | Strong Sell | $26.00 | N/A | Downgrades | 4 years ago |
Disc Medicine IncIRON | 2 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Valneva SeVALN | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 4 years ago |
Design Therapeutics IncDSGN | 1 | Hold | $28.00 | N/A | Initiates Coverage On | 4 years ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $31.00 | N/A | Initiates Coverage On | 4 years ago |
Vor Biopharma IncVOR | 1 | Strong Sell | $19.00 | N/A | Initiates Coverage On | 4 years ago |
Innate Pharma SaIPHA | 1 | Hold | $4.75 | N/A | Initiates Coverage On | 5 years ago |
Arcutis Biotherapeutics IncARQT | 2 | Strong Buy | $36.00 | N/A | Upgrades | 5 years ago |
Cytokinetics IncCYTK | 1 | Hold | $16.00 | N/A | Initiates Coverage On | 5 years ago |
Galapagos NvGLPG | 1 | Strong Sell | N/A | N/A | Downgrades | 5 years ago |
Prelude Therapeutics IncPRLD | 1 | Hold | $37.00 | N/A | Initiates Coverage On | 5 years ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Sell | $128.00 | N/A | Downgrades | 5 years ago |
Tricida IncTCDAQ | 1 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Flexion Therapeutics IncFLXN | 1 | Hold | $15.00 | N/A | Initiates Coverage On | 5 years ago |
Momenta Pharmaceuticals IncMNTA | 1 | Hold | $29.00 | N/A | Initiates Coverage On | 5 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.